ATE369339T1 - Pseudopolymorphe formen von carvedilol - Google Patents

Pseudopolymorphe formen von carvedilol

Info

Publication number
ATE369339T1
ATE369339T1 AT02777139T AT02777139T ATE369339T1 AT E369339 T1 ATE369339 T1 AT E369339T1 AT 02777139 T AT02777139 T AT 02777139T AT 02777139 T AT02777139 T AT 02777139T AT E369339 T1 ATE369339 T1 AT E369339T1
Authority
AT
Austria
Prior art keywords
pseudopolymorphous
carvedilol
forms
pseudopolymorphous forms
Prior art date
Application number
AT02777139T
Other languages
English (en)
Inventor
Andre Gerard Bubendorf
Rolf-Dieter Gabel
Michael Henning
Siegfried Krimmer
Guenter Neugebauer
Walter Preis
Alexander Wirl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE369339T1 publication Critical patent/ATE369339T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02777139T 2001-09-28 2002-09-18 Pseudopolymorphe formen von carvedilol ATE369339T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01123422 2001-09-28

Publications (1)

Publication Number Publication Date
ATE369339T1 true ATE369339T1 (de) 2007-08-15

Family

ID=8178782

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02777139T ATE369339T1 (de) 2001-09-28 2002-09-18 Pseudopolymorphe formen von carvedilol

Country Status (20)

Country Link
US (3) US20030119893A1 (de)
EP (1) EP1432681B1 (de)
JP (1) JP2005507899A (de)
KR (1) KR100752549B1 (de)
CN (1) CN1308307C (de)
AR (1) AR036689A1 (de)
AT (1) ATE369339T1 (de)
AU (1) AU2002338726B2 (de)
BR (1) BR0212927A (de)
CA (1) CA2460486A1 (de)
DE (1) DE60221683T2 (de)
ES (1) ES2291503T3 (de)
GT (1) GT200200198A (de)
MX (1) MXPA04002826A (de)
PA (1) PA8555201A1 (de)
PE (1) PE20030448A1 (de)
PL (1) PL370412A1 (de)
RU (1) RU2308449C2 (de)
UY (1) UY27461A1 (de)
WO (1) WO2003029214A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004501191A (ja) * 2000-06-28 2004-01-15 テバ　ファーマシューティカル　インダストリーズ　リミティド カルベジロール
MXPA04006909A (es) 2002-01-15 2005-04-19 Teva Pharma Solidos cristalinos de carvedilol y procesos para su preparacion.
MXPA04012923A (es) 2002-06-27 2005-03-31 Sb Pharmco Inc Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento.
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
US20070043099A1 (en) * 2005-06-09 2007-02-22 Igor Lifshitz Crystalline forms of carvedilol and processes for their preparation
WO2008002683A2 (en) * 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Polymorphous forms of carvedilol phosphate
US20080292695A1 (en) * 2006-12-01 2008-11-27 Kristin Arnold Carvedilol forms, compositions, and methods of preparation thereof
US20090028935A1 (en) * 2006-12-01 2009-01-29 Kristin Arnold Carvedilol forms, compositions, and methods of preparation thereof
US20080207726A1 (en) * 2007-02-26 2008-08-28 Santiago Ini Process for the purification of carvedilol or its salts thereof
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
TWI415604B (zh) * 2009-09-29 2013-11-21 Tsh Biopharm Corp Ltd 調控釋放卡菲蒂羅劑型
US20110229564A1 (en) * 2010-03-22 2011-09-22 Amneal Pharmaceuticals, L.L.C. Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten
GB9113802D0 (en) * 1991-06-26 1991-08-14 Smithkline Beecham Plc Medicaments
US5393772A (en) * 1993-11-24 1995-02-28 Boehringer Mannheim Pharmaceuticals Corporation Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation
EP0893440A1 (de) * 1997-07-22 1999-01-27 Roche Diagnostics GmbH Eine thermodynamisch stabile Modifikation von 1-(4-Carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]- 2-propanole, Verfahren zu ihrer Herstellung und ihre enthaltende Arznemittel
HU227441B1 (en) * 1997-11-24 2011-06-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing carvedilol, enantiomers and salts thereof
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
JP2004501191A (ja) * 2000-06-28 2004-01-15 テバ　ファーマシューティカル　インダストリーズ　リミティド カルベジロール

Also Published As

Publication number Publication date
AU2002338726B9 (en) 2003-04-14
DE60221683T2 (de) 2008-04-30
CN1308307C (zh) 2007-04-04
PE20030448A1 (es) 2003-06-19
CA2460486A1 (en) 2003-04-10
US20040198812A1 (en) 2004-10-07
UY27461A1 (es) 2003-06-30
AU2002338726B2 (en) 2007-03-15
ES2291503T3 (es) 2008-03-01
GT200200198A (es) 2003-06-19
PA8555201A1 (es) 2003-12-10
CN1558900A (zh) 2004-12-29
PL370412A1 (en) 2005-05-30
EP1432681A1 (de) 2004-06-30
AR036689A1 (es) 2004-09-29
DE60221683D1 (en) 2007-09-20
US20030119893A1 (en) 2003-06-26
JP2005507899A (ja) 2005-03-24
KR100752549B1 (ko) 2007-08-30
WO2003029214A1 (en) 2003-04-10
BR0212927A (pt) 2004-10-13
KR20040047872A (ko) 2004-06-05
EP1432681B1 (de) 2007-08-08
MXPA04002826A (es) 2004-07-02
US20060148878A1 (en) 2006-07-06
RU2308449C2 (ru) 2007-10-20
RU2004113209A (ru) 2005-05-20

Similar Documents

Publication Publication Date Title
DE60233133D1 (de) Polymorphe formen von 1-ä4-(5-cyanoindol-3-yl)butylü-4-(2-carbamoylbenzofuran-5-yl) piperazin-hydrochlorid
NO20023663D0 (no) Broplugg
ATE391502T1 (de) Kristalline formen von fluvastatin-natrium
DE02784674T1 (de) Quantifizierung von polypeptiden
DE50212455D1 (de) Verwendung von Dimerdiolen
ATE329177T1 (de) Reibungsdämpfendes bein
DE50200250D1 (de) Geminitenside
ATA19372001A (de) Federungsvorrichtung
ATE369339T1 (de) Pseudopolymorphe formen von carvedilol
IS2523B (is) Turn vindorkuvers
PT1421062E (pt) Novas ciclo-hexilsulfonas
NO20041968L (no) Anvendelse av cystationin
DK1406858T3 (da) Substituerede 4-aminocyklohexanoler
IS6884A (is) Aðferðir við að nýta líffræðilegan fjölbreytileika
DE60007360D1 (de) Amorphe modifikation von torasemid
ATA14062001A (de) Fassung
PT1395583E (pt) Novas fenilpiperazinas
DE50203046D1 (de) Verwendung von Esterquats
FR2830515B1 (fr) Suspension de turboreacteur
DE60222567D1 (de) Glutaminase
DE60216967D1 (de) Substituierte cyclohexanderivate
DE60233601D1 (de) Verwendung von bestimmten Cyclolignanen
DE50214478D1 (de) Aufhänger
FI20010467A0 (fi) Purkauslamppu
FI5213U1 (fi) Valaisin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1432681

Country of ref document: EP

REN Ceased due to non-payment of the annual fee